Skip to main content
Top
Published in: European Journal of Nutrition 4/2020

Open Access 01-06-2020 | Insulins | Original Contribution

Association of artificially sweetened and sugar-sweetened soft drinks with β-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht Study

Authors: Louise J. C. J. den Biggelaar, Simone J. S. Sep, Andrea Mari, Ele Ferrannini, Martien C. J. M. van Dongen, Nicole E. G. Wijckmans, Miranda T. Schram, Carla J. van der Kallen, Nicolaas Schaper, Ronald M. A. Henry, Marleen M. van Greevenbroek, Coen D. A. Stehouwer, Simone J. P. M. Eussen

Published in: European Journal of Nutrition | Issue 4/2020

Login to get access

Abstract

Purpose

Artificially sweetened and sugar-sweetened beverage consumptions have both been reported to be associated with type 2 diabetes mellitus (T2D) risk. The aim of the current study was to investigate the potential underlying associations with dynamic pancreatic β-cell function (BCF) and insulin sensitivity.

Methods

We evaluated cross-sectional associations in 2240 individuals (mean ± SD age 59.6 ± 8.18, 49.4% male, 21.9% T2D) participating in a diabetes-enriched population-based cohort. Artificially sweetened and sugar-sweetened soft drinks and juice consumption were assessed by a food-frequency questionnaire. Glucose metabolism status, insulin sensitivity, and BCF were measured by a seven-point oral glucose tolerance test. Regression analyses were performed to assess associations of artificially and sugar-sweetened beverage consumption with measures of glucose homeostasis. Associations were adjusted for potential confounders, and additionally with and without total energy intake and BMI, as these variables could be mediators.

Results

Moderate consumption of artificially sweetened soft drink was associated with lower β-cell glucose sensitivity [standardized beta (95% CI), − 0.06 (− 0.11, − 0.02)], total insulin secretion [β − 0.06 (− 0.10, − 0.02)], and with lower β-cell rate sensitivity [odds ratio (95% CI), 1.29 (1.03, 1.62)] compared to abstainers. Daily artificially sweetened soft drink consumption was associated with lower β-cell glucose sensitivity [β − 0.05 (− 0.09, 0.00)], and total insulin secretion [β − 0.05 − 0.09, − 0.01)] compared to abstainers.

Conclusions

Moderate and daily consumption of artificially sweetened soft drinks was associated with lower BCF, but not with insulin sensitivity. No evidence was found for associations of sugar-sweetened soft drink and juice consumption with BCF or insulin sensitivity in this middle-aged population. Prospective studies are warranted to further investigate the associations of artificially and sugar-sweetened beverage consumption with non-fasting insulin sensitivity and multiple BCF aspects.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization (2016) Global report on diabetes. World Health Organization, Geneva World Health Organization (2016) Global report on diabetes. World Health Organization, Geneva
5.
go back to reference Lana A, Rodríguez-Artalejo F, Lopez-Garcia E (2014) Consumption of sugar-sweetened beverages is positively related to insulin resistance and higher plasma leptin concentrations in men and nonoverweight women. J Nutr 144(7):1099–1105PubMedCrossRef Lana A, Rodríguez-Artalejo F, Lopez-Garcia E (2014) Consumption of sugar-sweetened beverages is positively related to insulin resistance and higher plasma leptin concentrations in men and nonoverweight women. J Nutr 144(7):1099–1105PubMedCrossRef
7.
go back to reference Yoshida M, McKeown NM, Rogers G, Meigs JB, Saltzman E, D’Agostino R, Jacques PF (2007) Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults. J Nutr 137(9):2121–2127PubMedCrossRef Yoshida M, McKeown NM, Rogers G, Meigs JB, Saltzman E, D’Agostino R, Jacques PF (2007) Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults. J Nutr 137(9):2121–2127PubMedCrossRef
9.
11.
go back to reference Cersosimo E, Solis-Herrera C, Trautmann ME, Malloy J, Triplitt CL (2014) Assessment of pancreatic beta-cell function: review of methods and clinical applications. Curr Diabetes Rev 10(1):2–42PubMedPubMedCentralCrossRef Cersosimo E, Solis-Herrera C, Trautmann ME, Malloy J, Triplitt CL (2014) Assessment of pancreatic beta-cell function: review of methods and clinical applications. Curr Diabetes Rev 10(1):2–42PubMedPubMedCentralCrossRef
12.
go back to reference Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, Caumo A, Butler P, Rizza R (2007) Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 293(1):E1–E15PubMedCrossRef Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, Caumo A, Butler P, Rizza R (2007) Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 293(1):E1–E15PubMedCrossRef
13.
go back to reference Mari A, Ferrannini E (2008) β-Cell function assessment from modelling of oral tests: an effective approach. Diabetes Obes Metab 10(s4):77–87PubMedCrossRef Mari A, Ferrannini E (2008) β-Cell function assessment from modelling of oral tests: an effective approach. Diabetes Obes Metab 10(s4):77–87PubMedCrossRef
15.
go back to reference Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65(4 Suppl):1220S–1228S (discussion 1229S–1231S) PubMedCrossRef Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65(4 Suppl):1220S–1228S (discussion 1229S–1231S) PubMedCrossRef
16.
go back to reference World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WH. World Health Organization, Geneva World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WH. World Health Organization, Geneva
18.
go back to reference den Biggelaar LJ, Sep SJ, Eussen SJ, Mari A, Ferrannini E, van Greevenbroek MM, van der Kallen CJ, Schalkwijk CG, Stehouwer CD, Dagnelie PC (2016) Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study. Diabetologia. https://doi.org/10.1007/s00125-016-4165-3 CrossRef den Biggelaar LJ, Sep SJ, Eussen SJ, Mari A, Ferrannini E, van Greevenbroek MM, van der Kallen CJ, Schalkwijk CG, Stehouwer CD, Dagnelie PC (2016) Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study. Diabetologia. https://​doi.​org/​10.​1007/​s00125-016-4165-3 CrossRef
19.
go back to reference Phillips D, Clark P, Hales C, Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11(3):286–292PubMedCrossRef Phillips D, Clark P, Hales C, Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11(3):286–292PubMedCrossRef
24.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470PubMedCrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470PubMedCrossRef
25.
go back to reference van Dongen MC, Wijckmans-Duysens NEG, den Biggelaar LJ, Ocke MC, Meijboom S, Brants HA, de Vries JH, Feskens EJ, Bueno-de-Mesquita HB, Geelen A, Stehouwer CD, Dagnelie PC, Eussen SJ (2019) The Maastricht FFQ: development and validation of a comprehensive food frequency questionnaire for the Maastricht study. Nutrition (Burbank, Los Angeles County, Calif) 62:39–46. https://doi.org/10.1016/j.nut.2018.10.015 CrossRef van Dongen MC, Wijckmans-Duysens NEG, den Biggelaar LJ, Ocke MC, Meijboom S, Brants HA, de Vries JH, Feskens EJ, Bueno-de-Mesquita HB, Geelen A, Stehouwer CD, Dagnelie PC, Eussen SJ (2019) The Maastricht FFQ: development and validation of a comprehensive food frequency questionnaire for the Maastricht study. Nutrition (Burbank, Los Angeles County, Calif) 62:39–46. https://​doi.​org/​10.​1016/​j.​nut.​2018.​10.​015 CrossRef
28.
go back to reference Consortium I (2013) Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 56(7):1520–1530CrossRef Consortium I (2013) Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 56(7):1520–1530CrossRef
29.
go back to reference Hayes AF, Preacher KJ (2014) Statistical mediation analysis with a multicategorical independent variable. Br J Math Stat Psychol 67(3):451–470PubMedCrossRef Hayes AF, Preacher KJ (2014) Statistical mediation analysis with a multicategorical independent variable. Br J Math Stat Psychol 67(3):451–470PubMedCrossRef
30.
go back to reference Engel S, Tholstrup T, Bruun JM, Astrup A, Richelsen B, Raben A (2018) Effect of high milk and sugar-sweetened and non-caloric soft drink intake on insulin sensitivity after 6 months in overweight and obese adults: a randomized controlled trial. Eur J Clin Nutr 72(3):358PubMedCrossRef Engel S, Tholstrup T, Bruun JM, Astrup A, Richelsen B, Raben A (2018) Effect of high milk and sugar-sweetened and non-caloric soft drink intake on insulin sensitivity after 6 months in overweight and obese adults: a randomized controlled trial. Eur J Clin Nutr 72(3):358PubMedCrossRef
31.
go back to reference Grotz VL, Pi-Sunyer X, Porte D Jr, Roberts A, Trout JR (2017) A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis. Regul Toxicol Pharmacol 88:22–33PubMedCrossRef Grotz VL, Pi-Sunyer X, Porte D Jr, Roberts A, Trout JR (2017) A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis. Regul Toxicol Pharmacol 88:22–33PubMedCrossRef
33.
go back to reference Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR (2009) Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 32(4):688–694PubMedPubMedCentralCrossRef Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR (2009) Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 32(4):688–694PubMedPubMedCentralCrossRef
35.
go back to reference Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D’Agostino RB, Gaziano JM, Vasan RS (2007) Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 116(5):480–488PubMedCrossRef Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D’Agostino RB, Gaziano JM, Vasan RS (2007) Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 116(5):480–488PubMedCrossRef
36.
go back to reference Fagherazzi G, Vilier A, Sartorelli DS, Lajous M, Balkau B, Clavel-Chapelon F (2013) Consumption of artificially and sugar-sweetened beverages and incident type 2 diabetes in the Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l’Education Nationale-European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr 97(3):517–523PubMedCrossRef Fagherazzi G, Vilier A, Sartorelli DS, Lajous M, Balkau B, Clavel-Chapelon F (2013) Consumption of artificially and sugar-sweetened beverages and incident type 2 diabetes in the Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l’Education Nationale-European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr 97(3):517–523PubMedCrossRef
37.
go back to reference Palmer JR, Boggs DA, Krishnan S, Hu FB, Singer M, Rosenberg L (2008) Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med 168(14):1487–1492PubMedPubMedCentralCrossRef Palmer JR, Boggs DA, Krishnan S, Hu FB, Singer M, Rosenberg L (2008) Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med 168(14):1487–1492PubMedPubMedCentralCrossRef
38.
go back to reference Sakurai M, Nakamura K, Miura K, Takamura T, Yoshita K, Nagasawa S, Morikawa Y, Ishizaki M, Kido T, Naruse Y (2014) Sugar-sweetened beverage and diet soda consumption and the 7-year risk for type 2 diabetes mellitus in middle-aged Japanese men. Eur J Nutr 53(1):251–258PubMedCrossRef Sakurai M, Nakamura K, Miura K, Takamura T, Yoshita K, Nagasawa S, Morikawa Y, Ishizaki M, Kido T, Naruse Y (2014) Sugar-sweetened beverage and diet soda consumption and the 7-year risk for type 2 diabetes mellitus in middle-aged Japanese men. Eur J Nutr 53(1):251–258PubMedCrossRef
39.
go back to reference Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514(7521):181–186PubMedCrossRef Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514(7521):181–186PubMedCrossRef
42.
go back to reference Bhupathiraju SN, Pan A, Malik VS, Manson JE, Willett WC, van Dam RM, Hu FB (2013) Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr 97:155–166PubMedCrossRef Bhupathiraju SN, Pan A, Malik VS, Manson JE, Willett WC, van Dam RM, Hu FB (2013) Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr 97:155–166PubMedCrossRef
43.
44.
go back to reference Montonen J, Jarvinen R, Knekt P, Heliovaara M, Reunanen A (2007) Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr 137(6):1447–1454PubMedCrossRef Montonen J, Jarvinen R, Knekt P, Heliovaara M, Reunanen A (2007) Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr 137(6):1447–1454PubMedCrossRef
46.
go back to reference Borai A, Livingstone C, Kaddam I, Ferns G (2011) Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol 11(1):158PubMedPubMedCentralCrossRef Borai A, Livingstone C, Kaddam I, Ferns G (2011) Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol 11(1):158PubMedPubMedCentralCrossRef
Metadata
Title
Association of artificially sweetened and sugar-sweetened soft drinks with β-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht Study
Authors
Louise J. C. J. den Biggelaar
Simone J. S. Sep
Andrea Mari
Ele Ferrannini
Martien C. J. M. van Dongen
Nicole E. G. Wijckmans
Miranda T. Schram
Carla J. van der Kallen
Nicolaas Schaper
Ronald M. A. Henry
Marleen M. van Greevenbroek
Coen D. A. Stehouwer
Simone J. P. M. Eussen
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 4/2020
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-019-02026-0

Other articles of this Issue 4/2020

European Journal of Nutrition 4/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.